Abstract
Background The test-trace-isolate-quarantine (TTIQ) strategy is used to break chains of transmission during a disease outbreak and is one of the key pillars of the non-pharmaceutical interventions to suppress the ongoing SARS-CoV-2 pandemic. Here we quantify how the probability of detecting and isolating a case, the fraction of contacts identified and quarantined, and the delays that are inherent to these processes impact the reduction of disease transmission by TTIQ.
Methods We develop an analytical model of disease transmission that is based on empirical distributions of the timing of SARS-CoV-2 transmission. The isolation of confirmed cases and quarantine of their contacts is implemented by truncating their respective infectious periods. Using this model we quantify how the parameters describing the coverage of the TTIQ intervention and the inherent delays impact the level of disease transmission. We provide an online application to assess the efficacy of TTIQ as a function of these parameters.
Findings Increasing the coverage of testing and isolating index cases has the largest effect on transmission reduction, followed by reducing the delay between symptom onset and index case isolation. The impacts of these two changes are substantially greater than the effect of increasing the fraction of contacts which are traced and subsequently quarantined or reducing the delay to quarantine. We find that, on average, increasing testing and isolation coverage and reducing the delay to isolation have four-fold and three-fold greater impacts, respectively, on transmission reduction compared to increasing contact tracing coverage. Increasing the duration of lookback in which contacts are identifiable has limited impact on TTIQ efficacy.
Interpretation To be a successful intervention strategy, TTIQ requires intensive testing. The majority of transmission is prevented by isolating symptomatic individuals, and doing so in a short amount of time. Despite the lesser impact, adding contact tracing and quarantine to testing and isolation increases the parameter space in which an epidemic is controllable, and is necessary to control epidemics with a high reproductive number. Our results show how TTIQ can be improved and optimised.
Funding This work was supported by the Swiss National Science Foundation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swiss National Science Foundation. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB necessary
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Code is publicly available at http://github.com/ashcroftp/ttiq2020.
Our model now explicitly accounts for asymptomatic infections. General improvements to presentation.
Data Availability
Code is publicly available at https://github.com/ashcroftp/COVID-TTIQ
